BrightSpring Health Services (NASDAQ:BTSG) Upgraded at Zacks Research

Zacks Research upgraded shares of BrightSpring Health Services (NASDAQ:BTSG) from a hold rating to a strong-buy rating in a research note published on Tuesday morning,Zacks.com reports.

Several other analysts have also commented on BTSG. William Blair initiated coverage on BrightSpring Health Services in a report on Monday, December 8th. They set an “outperform” rating on the stock. BTIG Research reaffirmed a “buy” rating and set a $55.00 price objective on shares of BrightSpring Health Services in a research note on Monday. Mizuho boosted their target price on shares of BrightSpring Health Services from $45.00 to $50.00 and gave the company an “outperform” rating in a research note on Tuesday. TD Cowen reissued a “buy” rating on shares of BrightSpring Health Services in a report on Monday. Finally, Wall Street Zen cut shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 15th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $44.08.

BrightSpring Health Services Trading Down 0.5%

Shares of BrightSpring Health Services stock opened at $41.77 on Tuesday. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12. The firm has a fifty day moving average price of $39.42 and a 200 day moving average price of $33.78. BrightSpring Health Services has a 1 year low of $15.48 and a 1 year high of $44.87. The stock has a market cap of $8.08 billion, a PE ratio of 47.47, a price-to-earnings-growth ratio of 0.57 and a beta of 2.31.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). The company had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion. BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.BrightSpring Health Services’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.11 earnings per share. Equities research analysts predict that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Institutional Trading of BrightSpring Health Services

A number of institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC purchased a new position in BrightSpring Health Services in the 1st quarter valued at about $276,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of BrightSpring Health Services by 5.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 32,429 shares of the company’s stock valued at $587,000 after acquiring an additional 1,780 shares during the last quarter. Millennium Management LLC lifted its position in shares of BrightSpring Health Services by 0.3% in the first quarter. Millennium Management LLC now owns 577,885 shares of the company’s stock valued at $10,454,000 after acquiring an additional 1,967 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of BrightSpring Health Services by 11.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 147,280 shares of the company’s stock worth $2,664,000 after acquiring an additional 14,586 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its position in shares of BrightSpring Health Services by 38.9% during the second quarter. Envestnet Asset Management Inc. now owns 20,226 shares of the company’s stock worth $477,000 after purchasing an additional 5,663 shares in the last quarter.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Morgan Stanley raised its price target to $48 and kept an “overweight” rating, signaling analyst conviction and around mid-teens upside to recent levels. Article Title
• Positive Sentiment: Wells Fargo increased its price target to $50, another high-profile price-target lift that supports further upside expectations. Article Title
• Positive Sentiment: Zacks upgraded BTSG to a “Strong Buy” (Rank #1) and published multiple pieces noting momentum, inclusion on growth/momentum lists, and upward earnings-estimate revisions — all can attract buyers and algos. Article Title
• Positive Sentiment: Mizuho and other outlets flagged strong upside potential and noted elevated trading volume after analyst coverage changes — higher attention/liquidity can amplify moves. Article Title
• Neutral Sentiment: Several Zacks pieces compare BTSG favorably to peers and highlight it as a fast-moving value/momentum candidate; useful context but not a direct catalyst by itself. Article Title
• Neutral Sentiment: Short-interest reports in the feed show zero shares / NaN changes (data appears erroneous or not meaningful) — no reliable short-squeeze signal at present.
• Negative Sentiment: Most-recent quarterly results included a very slight EPS miss ($0.33 vs. $0.34 consensus) despite a revenue beat and strong year-over-year revenue growth; minor near-term headline risk for short-term traders.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.